Blepharospasm as a tardive manifestation of COVID-19 disease: A case report
- PMID: 36727386
- PMCID: PMC10228920
- DOI: 10.4103/ijo.IJO_1658_22
Blepharospasm as a tardive manifestation of COVID-19 disease: A case report
Abstract
We report three cases of blepharospasms developed after a symptomatic COVID-19 infection, in order to describe a possible association between COVID-19 infection and essential blepharospasm. Blepharospasm could represent a late sign of COVID-19 infection (more than four weeks after the contagion) and may be triggered by the neurotropism of the coronavirus.
Keywords: 2020 pandemic; COVID-19; blepharospasm; facial dystonia.
Conflict of interest statement
None
Figures
Comment on
-
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11. J Med Virol. 2020. PMID: 32104915 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
